<?xml version="1.0" encoding="UTF-8"?>
<ref id="B71-vaccines-08-00224">
 <label>71.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Soresina</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Moratto</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Chiarini</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Paolillo</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Baresi</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Foca</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Bezzi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Baronio</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Giacomelli</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Badolato</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover</article-title>
  <source>Pediatr. Allergy Immunol.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1111/pai.13263</pub-id>
 </element-citation>
</ref>
